Kiniksa Pharmaceuticals
UnverifiedFacts from public sources. Is this your company? Claim your page.BiotechLondon, England (principal executive offices); US operations in Lexington, MassachusettsNasdaq: KNSA
The Lobby built this page from public sources. It isn’t maintained by or affiliated with Kiniksa Pharmaceuticals. Is this your company? Claim your page (free).
Overview
Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company focused on cardiovascular indications, with deep expertise in immunology and inflammation. Its lead product, ARCALYST, an IL-1α and IL-1β cytokine trap, is FDA-approved for recurrent pericarditis, CAPS and DIRA, and recurrent pericarditis is the primary indication it commercializes through a specialized US cardiology sales team. Kiniksa's principal executive offices are in London, with US operations in Lexington, Massachusetts.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Kiniksa Pharmaceuticals’s careers page.
- Clinical Sales Specialist- SeattleSeattle Metro, Washington5d ago$195k–$205k base
- Clinical Sales Specialist- Santa MonicaSanta Monica, California5d ago$195k–$205k base
- Clinical Sales Specialist- Northern ColoradoColorado +15d ago$195k–$205k base
- Clinical Sales Specialist- MinneapolisMinneapolis, Minnesota5d ago$195k–$205k base
- Clinical Sales Specialist- AlbuquerqueAlbuquerque, New Mexico5d ago$195k–$205k base
- Regional Sales Director - WestLocation not listed18d ago$250k–$270k base
Divisions
Division information is pending company verification.Once Kiniksa Pharmaceuticals claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Kiniksa Pharmaceuticals
These sections fill in when Kiniksa Pharmaceuticals claims and verifies its page.